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ABSTRACT 
Objective: The objectives of present investigation were to prepare and evaluate proniosomes of neomycin sulphate (NS) by coacervation phase 
separation method by using sorbitan monostearate (span 60) and lecithin as a surfactant to increase the penetration through the skin and study the 
effect of concentration of the same. 
Methods: Proniosomes of neomycin sulphate (NS) were prepared by coacervation phase separation method by using span 60 and lecithin. The 
effect of concentration of span 60 and lecithin was studied by factorial design. The prepared proniosomes were converted to gel by using carbopol 
as a gelling agent. The prepared formulations were evaluated for entrapment efficiency, in vitro drug diffusion, in vitro antibacterial activity and in 
vivo skin irritation test etc. 
Results: All Formulation showed the percentage entrapment efficiency in the range 38.31±0.05% to 77.96±0.06%, good homogeneity and gel was 
easily spreadable with minimal of shear. Optimized formulation showed enhanced rate of diffusion in vitro, increase in zone of inhibition against 
staphylococcus aureus, no skin irritation and showed good stability. 
Conclusion: The results of present study indicates that proniosomal gel formulated by using combination of span 60, Lecithin, cholesterol can be 
used to enhance skin delivery of NS because of excellent permeation of drug. Developed proniosomal gel formulation was promising carrier for NS 
Keywords: Proniosomes, Neomycin Sulphate, Sorbitane monostearate (span 60), Lecithin and Cholesterol 




Oral route of administration is most accepted route for majority of 
drugs but still faces challenges as compared to other routes. 
Transdermal route gives better control of blood level, reduce 
systemic toxicity, it protects drug from the hepatic first pass 
metabolism, better patient compliance and can be a potential option 
for oral dosage forms. Human skin is the important target site for 
the application of drug especially in the treatment of local disease. 
Penetration enhancement with special formulation approaches is 
mainly based on the usage of colloidal carriers [1]. Colloidal carrier 
have distinct advantages over conventional drug delivery as it act as 
drug containing reservoirs, modification of the particle composition 
or surface can adjusts the release rate to the target site [2]. These 
carriers accumulate in stratum corneum or other upper skin layers 
and are not expected to penetrate into viable skin. The penetration 
enhancement is the most critical factor in the transdermal drug 
delivery [3]. Hence it is necessary to increase the flux through skin 
membrane by using different approaches of penetration 
enhancement. Vesicular systems have been widely studied as 
vehicles for dermal and transdermal drug delivery. A number of 
vesicles systems such as liposomes, niosomes, ethosomes, 
emulsomes and transfersomes have been developed. The vesicular 
carrier such as niosomes has distinct advantage over conventional 
dosage forms because these particles can act as drug reservoir [1-2]. 
Compounds having high molecular weight cannot cross skin, need some 
amendment owing to the availability of novel methods that might 
enhance the transport of large molecular weight compounds into or 
through the skin. Vesicular systems especially niosomes and liposomes 
are well established system for the transdermal route but the stabilityis 
the major problem of these carriers. Liposome exhibits some difficulties 
such as instability of aqueous dispersions on storage and the leakage of 
the encapsulated drugs. Also the high cost of synthetic phospholipids. 
An alternative approach i.e. niosomes that overcomes several of these 
problems associated with liposomes [3]. Non-ionic surfactant vesicles 
obtained on hydration of synthetic non-ionic surfactants, with or 
without incorporation of cholesterol or other lipid [4]. But the 
proniosomes are more advantageous than nonionic surfactant vesicles 
i.e., niosomes, in terms of physical stability such as aggregation, fusion 
and leaking, and provide additional convenience in transportation, 
distribution, storage, and dosing [5]. Proniosomes encloses both 
hydrophilic and lipophilic drugs. Proniosomes reduce the toxicity 
related to drug because of their non-ionic nature of surfactant [6]. 
Neomycin Sulphate is a bactericidal aminoglycoside antibiotics (or 
antibacterial agent) is categorized as a BCS class-III i.e. high solubility 
and poor permeability, and generally it used as topical agent in skin 
infection. Physicochemical properties of NS like highly polar nature 
and high molecular weight (908.87D). Poor skin permeability (<3%) of 
Neomycin sulphate reduces its deeper penetration in skin [7]. That 
aminoglycoside antibiotic works by binding to the bacterial 30S 
ribosomal subunit, causing misreading of t-RNA, leaving the bacterium 
unable to synthesize proteins vital to its growth [8-10]. In present 
investigation proniosomal gel of NS was prepared by using span 60 
and lecithin to increase the skin penetration. 
MATERIALS AND METHODS 
Materials 
Neomycin Sulphate was obtained as a gift sample from Encube Ethical 
Pvt. Ltd. Goa. Span 60, Cholesterol and carbopol 934 were purchased 
from Loba Chemicals, Mumbai. Lecithin was purchased from Research 
lab Mumbai. All other ingredients were of analytical grade. 
Formulation of proniosomal gel 
Proniosomes were prepared by the modified literature method 
reported by Fang et al. 2001 [11]. Proniosomes prepared by co-
acervation phase separation method. Precisely weighed amount of 
drug, surfactant, cholesterol, lecithin, and organic solvent (Ethanol) 
taken in wide mouth container. After mixing all ingredients, the 
open end of glass tube was covered with a lid to prevent loss of 
solvent from it and warmed on water bath at 60-70 °c for about 10 
min, until the surfactants were dissolved completely. Then aqueous 
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phase Phosphate buffer pH 7.4 was added and the mixture was 
further warmed in the water bath for about 2 min. so that a clear 
solution was obtained. The mixture was allowed to cool to room 
temperature until the dispersion was converted to proniosomal gel. 
Carbopol 934 was added in formulation in 1:1 ratio. 
Effect of variables 
To study the effect of variables by using 32
 
 factorial designs was 
applied for optimization of proniosomal gel formulation shown in 
table 1. In this study two factors were evaluated each at three levels 
and experimental trials were performed at all nine possible 
combinations. The amount of surfactant and lecithin were selected 
as independent variables. The percentage entrapment efficiency and 
percentage drug release was selected as dependent variables. Here 
the cholesterol concentration was kept constant at 10% because of 
the concentration of cholesterol above 10 % then it might lead to 
decreases % entrapment efficiency and forms more rigid bilayer and 
also decrease % drug release [12]. 
Table 1: Composition of formulation 
S. No. Formulation code Drug (mg) Surfactant span 60 (mg) Lecithin (mg) Cholesterol (mg) 
1 PG1 5 0.7 0.2 0.1 
2 PG2 5 0.7 0.5 0.1 
3 PG3 5 0.7 0.8 0.1 
4 PG4 5 0.4 0.2 0.1 
5 PG5 5 0.4 0.5 0.1 
6 PG6 5 0.4 0.8 0.1 
7 PG7 5 0.1 0.2 0.1 
8 PG8 5 0.1 0.5 0.1 
9 PG9 5 0.1 0.8 0.1 
 
Physical evaluation of gels 
The prepared gel formulations were evaluated for physical appearance, 
pH, homogeneity, spread ability and viscosity by using conventional 
digital R/S plus Rheometer Brookfield Engineering Lab Inc. (USA) 
Microscopic evaluation 
In glass tube, 0.2 gm proniosomal gel of all formulation was diluted 
with 10 ml of pH 7.4 phosphate buffer; few drop of formed niosomal 
dispersion were spread on a glass slide and examined for the vesicles 
structure using ordinary light microscope with varied magnification 
power. Photomicrographs were taken for niosomes at 100X. 
Entrapment efficiency 
It was determined indirectly i.e. by calculating the amount of un-
entrapped drug as shown in equation 1. To 0.2 g of proniosome gel 
10 ml of phosphate buffer pH 7.4 was added. The niosomes were 
separated from untrapped drug by centrifugation at 5000 rpm for 
30 min and evaluating the supernatant spectrophotometrically 
(Shimadzu–1601, Tokyo) at 277 nm with suitable dilution. 
Entrapment efficiency was calculated by using following formula, 
% Entrapment Efficiency = (Ct-Cr)/Cr x100 ………………… 1 
Where,Ct = Concentration of total drug, Cr = Concentration of free drug 
Vesicle size analysis 
Particle size and zeta potential of formulation was determined by 
using Malvern Zetasizer instrument v2.1. 
In vitro ex-vivo permeation study 
These studies were performed using locally Fabricated Keshary-
Chientype diffusion cell with an area of 2.1 cm2
Drug release kinetics 
 (Sigma, Inc. Mo. 
USA). The capacity of receptor compartment was 20 ml. The dialysis 
membrane and human cadaver skin was mounted between the 
donor and receptor compartment. A weighed amount of 
proniosomal gel was placed on one side of the membrane. The 
receptor medium was containing phosphate buffer pH 7.4 with 
continuous rotation speed of 50 rpm by using magnetic stirrer. The 
receptor compartment was surrounded by a water jacket to 
maintain the temperature at 37±0.5°C. At each sampling interval 
during 24 h, 1 mlwas withdrawn and was replaced by equal volumes 
of fresh receptor fluid on each occasion. Samples withdrawn were 
analyzed by UV-visible double beam spectrophotometer (Shimadzu-
1601, Tokyo) at 277 nm by using furfural assay of NS [5]. 
The release data obtained from various formulations werestudied 
further for their fitness of data in different kineticmodels like zero order, 
first order, Higuchi model, Hixoncrowell and Korsemeyer peppa’s model. 
In vitro antimicrobial activity 
This study was carried out by using Agar-cup diffusion method and 
Staphylococcus Aureus culture was used. The nutrient agar broth was 
used as a media. The subculture of Staphylococcus Aureus culture 
was spread in petri-dish. (Bacterial strains were obtained from 
faculty of allied sciences, Microbiology and Biotechnology KIMSDTU, 
Karad) On solidification, 1 cm holes were made and filled with a 
formulation. The one plate hole filled with pure NS solution, second 
plate hole filled with marketed NS cream formulation 
Stability studies 
The ability of vesicles to retain the drug was assessed by keeping the 
proniosomal gel at ambient temperature. Throughout the study, 
proniosomal formulations were stored in stoppered glass vials. 
Entrapment efficiency of formulations were determined before and 
after completion of one month and measurement were made by 
spectrophotometer(Shimadzu-1601, Tokyo) at 277 nm  
Skin irritation study 
The skin irritation studies was performed using healthy albino 
Wistar rats (220-300 gm) obtained from TKCP Warnanagar and 
were housed in polypropylene cages, with laboratory diet and water. 
Animals were acclimatized for period of 24 h to ensure their 
suitability for Study. The dorsal abdominal skin of rats was shaved 
24 h before study. Optimized proniosomal gel was applied on dorsal 
skin and application site was occluded with gauze and covered with 
a nonsensitzing micro porous tapes. After 24 h the formulation was 
removed, and development of erythema was recorded [Approval 
Letter no. IAEC/TKCP/2014/13]. 
RESULTS AND DISCUSSION 
The physical appearance of the gel was observed by eyes. All 
proniosomal gel formulations were yellowish in colour as shown in 
table 2. It might be due to brown colour of soya lecithin [7]. 
The pH of all formulations was found in ranged from 6.5-7.1 given in 
table 2 and that pH suitable to skin pH [13]. It reveales that the 
formulations will be compatible with skin. 
All developed proniosomal gel formulations showed good 
homogeneity with absence of lumps (table 2). The value of 
spreadability of all proniosomal formulations ranged from 4.5±0.01 
to 6.9±0.02 (g. cm/sec) shown in table 2. The value of spreadability 
indicate that the gel is easily spreadable with minimal of shear [14]. 
Viscosity determination 
All proniosomal gel formulations were semisolid in consistency as 
required for skin application except the PG9 formulation, which had 
softer consistency (table 2). The consistency of the gel increased 
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because of the molecular interaction of polar head groups of 
surfactant with the solvent and permeation of solvent into the 
bilayers. The solvent diffusion into the bilayers did not disturb the 
liquid crystalline structure. It results in complete bilayer formation 
due to the saturation of the lipid polar heads. This might have lead to 
an increase in bilayers distance resulting in an overall increase in 
consistency [15]. One another reason of increased consistency due 
to the loss of alcohol upon storage [14, 15]. 
 
Table 2: Physical characterization of proniosomal gel 
S. No. Formulation code Appear-ance pH* Homoge- neity Spreadability* (g. cm/sec) Viscosity* (cP) 
1 PG1 Yellowish 6.8±0.02 Good 4.5±0.01 471.87±0.04 
2 PG2 Yellowish 6.9±0.05 Good 5.1±0.05 391.68±0.01 
3 PG3 Yellowish 7.1±0.01 Good 5.3±0.03 354.82±0.03 
4 PG4 Yellowish 6.5±0.03 Good 4.7±0.02 421.52±0.06 
5 PG5 Yellowish 6.7±0.06 Good 6.2±0.04 312.90±0.02 
6 PG6 Yellowish 6.9±0.03 Good 6.6±0.01 251.48±0.04 
7 PG7 Yellowish 6.9±0.02 Good 6.7±0.03 249.86±0.01 
8 PG8 Yellowish 7.0±0.01 Good 6.7±0.05 158.63±0.06 
9 PG9 Yellowish 6.9±0.04 Good 6.9±0.02 104.83±0.02 
*Above values indicate mean±SD (n=3) 
 
Microscopic determination 
After hydration of proniosomes by using phosphate buffer the 
niosomal suspension was formed which was seen under the 
microscope. The photomicrographs of all formulations are shown 
in fig. 1. Most of vesicles are well identified; spherical in shape 
having large internal aqueous space niosomes were observed. 
Addition of water with polar groups of surfactant. In presence of 
excess of water there was complete hydration leading to formation 
of niosomes [16]. 
 
 
Fig. 1: Photomicrographs of prepared formulations 
 
Percentage entrapment efficiency 
Entrapment efficiency of proniosomes formulations ranged from 
38.31% to 77.96%. The drug encapsulation efficiency of all nine 
formulations is shown in table 3. PG3 formulation had showed good 
encapsulation efficiency. The effect of concentration of lecithin on 
entrapment efficiency is shown in table 3. Increase in lecithin 
concentration increases percentage entrapment efficiency. This might 
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be due to lecithin containing long hydrocarbon chain of lecithin [15, 
17]. Therefore they increase the vesicle size of niosomes and increase 
percentage entrapment efficiency [17]. Effect of amount of surfactant 
on entrapment efficiency. Initially increase the concentration of 
surfactant i.e. span 60 might be increased number of niosomes formed 
because of the volume of hydrophobic domain increases, hence 
increasing entrapment efficiency. However further increase in the 
concentration of surfactant decrease entrapment efficiency.  
It might be due to formation of mixed micelles along with niosomal 
vesicles which leads fewer amount of drug might be entrapped inside 
the vesicle. This leads to lower entrapment efficiency [18]. 
 
Table 3: Entrapment efficiency of proniosomes formulations 
S. No. Formulation code %EE* 
1 PG1 38.31±0.05 
2 PG2 64.06±0.03 
3 PG3 77.96±0.06 
4 PG4 44.92±0.01 
5 PG5 72.14±0.04 
6 PG6 60.12±0.02 
7 PG7 61.55±0.05 
8 PG8 66.67±0.01 
9 PG9 76.49±0.03 
*Above values indicate mean±SD (n=3) 
 
Vesicle size analysis 
The particle size was found in the ranged from 153.1±0.03 to 
435.9±0.04 as shown in table 4. proniosomes prepared by using 
combination of span 60 and lecithin showed increase in particle size 
at the optimum concentration. These results suggest that addition of 
lecithin leads to increase in particle size. This might be due to the 
lecithin contains long hydrocarbon chains [17, 19]. The relationship 
observed between proniosomes size and hydrophobicity has been 
attributed to the decrease in surface energy with increase in 
hydrophobicity, resulting in the smaller vesicles. The larger vesicles 
size of proniosomes prepared with high concentration of lecithin 
which has much lower hydrophobicity than the high concentration 
of span 60. Because increase in amount of span 60, increase in 
hydrophobicity which leads to decrease in vesicle size. The 
differences in vesicle size among the proniosomes prepared with 
different ratio of span 60 and lecithin [20]. 
All formulations showed low value of polydispesity index. 
Polydispesity index is the ratio of standard deviation to the mean 
particle size and it signifies the uniformity of particle size within the 
formulation. The polydispesity values of formulation were found<1 
(0.428-0.746). It indicates that narrow distribution and uniformity 
of particle size within formulation [7, 15]. 
Zeta potential determination 
Zeta potential of optimized formulation i.e. PG3 formulations is 
shown in fig. 3. The value of zeta potential was found to be-31.18 mV 
and hence it indicates that the prepared formulations was stable 
[20].
 
Table 4: Particle size analysis of proniosomes formulations 
S. No. Formulation code Particle size* (nm) PDI 
1 PG1 153.1±0.03 0.428 
2 PG2 290.3±0.01 0.470 
3 PG3 404.5±0.02 0.746 
4 PG4 156.6±0.05 0.450 
5 PG5 365.8±0.08 0.590 
6 PG6 349.7±0.03 0.673 
7 PG7 349.7±0.05 0.673 
8 PG8 357.4±0.01 0.631 
9 PG9 435.9±0.04 0.600 
*Above values indicate mean±SD (n=3) 
 
Table 5: Zeta potential distribution of optimized formulation (PG3 formulation) 
S. No. Formulation code Zeta potential (mV) 
1 PG3 -31.18 
 
In vitro ex-vivo permeation study 
The PG3 and PG9 formulation showed a more permeation of 
drug78.39±0.05 % and 80.06±0.01 % respectively over the period of 
24 h through dialysis membrane as compared to other formulations 
and carbopol gel containing pure NS as it contains more 
concentration of lecithin [3, 15, 17]. But this formulation was less 
viscous as shown in table 2. The PG3 formulation showed optimum 
drug release due to the optimum concentration of span60 and 
lecithin. On the basis of entrapment efficiency, in vitro drug diffusion 
study through the dialysis membrane, spreadability, and viscosity, 
the formulation PG3 (combination of span 60 and lecithin) was 
concluded as optimized formulation. Hence PG3 formulation was 
further subjected to ex-vivo permeation studies. The cumulative 
drug diffusion of NS carbopol gel and PG3 formulation through 
human cadaver skin in phosphate buffer pH 7.4 was found to be 
17.93±0.04 % and 63.76±0.01 respectively over the period of 24 h. 
Fig. 2 and 3 revealed that the proniosomal gel formulation had highest 
cumulative amount of drug diffusion as compared to carbopol 
containing pure Neomycin Sulphate. It might be due to the vesicles 
acts as penetration enhancers to reduce the barrier properties of 
stratum corneum [7, 21]. The possible reason for niosomes to enhance 
the permeability of drug through the skin is depends upon structure of 
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skin. Formulation contains surfactant and phospholipid. The 
phospholipid is fluidizing both the vesicle and the SC lipids such as 
ceramides etc. and surfactant i.e. span 60 forms the vesicles are more 
flexible. Phospholipid disturbs structure of the intracellular lipid 
bilayers in stratum corneum (SC) and increases their fluidity. 
Niosomes are entered into disturbed SC bilayers through the skin 
lipids. Thus, resulting the drug release from niosomal vesicles in skin 
due to the fusion vesicles with skin lipids [7, 14, 21, 22]. 
 
 
Fig. 2: In vitro drug diffusion study of prepared formulations 
 
 
Fig. 3: Comparative diffusion study of plain and proniosomal gel 
 
Kinetics of drug release 
Table 6 represents the value of R2
 
for PG3 formulations was found 
higher i.e. 0.926 for zero order model. Hence the zero order models 
mostly fitted the in vitro release profile of NS proniosomal gel 
formulation. The value of diffusion exponent (slope) n was found to 
be 2.422. Therefore, the drug release rate from PG3 formulation was 
controlled predominantly by super case II transport diffusion [14].
Table 6: Release Kinetic data of PG3 formulation 
S. No. Formulation code Regression coefficient (R2) 
Zero order First order Higuchi model Hixon crowell model Korsmeyer-peppas model 
1 PG3 0.926 0.611 0.889 0.750 0.807 
 
Statistical data 
The variation in the concentration of lecithin significantly affects the 
entrapment efficiency and percentage drug diffusion (p<0.05). Fig. 4 
and 5 represent that entrapment efficiency and % drug diffusion 
depends upon both surfactant and lecithin. 3D response surface 
plots give a representation of the variations in each response when 
the two factors are simultaneously changed from lower to different 
factor levels. It also gives the variation in design points from the 
predicted response value [23-25]. 
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Fig. 4: 3 D surface response plot of effect of concentration of lecithin and span 60 on entrapment efficiency 
 
 
Fig. 5: 3 D surface response plot of effect of concentration of lecithin and span 60 on drug release or diffusion 
 
In vitro antimicrobial activity 
The microbial activity studies showed greater potential of 
vesicular system (in comparison to marketed cream 
formulation) to inhibit the growth of Staphylococcus aureus. The 
zone of inhibition values of proniosomal gel formulation (PG3), 
marketed formulation (MK) and standard NS solution were 
found to be 13±0.01, 12.4±0.04 and 12±0.02 mm, respectively as 
shown in table 7 [26-27].  
The enhanced antimicrobial activity of NS may be attributed to 
enhanced penetration of vesicles containing NS through 
bacterial cell wall to inhibit protein synthesis its essential for 
growth of bacteria [8]. The result indicates that the proniosomal 
formulation is better carrier system for the efficient skin 
delivery of NS [14]. 
Stability study 
The sample was analyzed for entrapment efficiency by using 
centrifugation method, in vitro diffusion study, physical appearance 
and consistency by using optical microscopy. From the results, it 
was revealed that consistency of proniosomal gel slightly changed 
after one month. It might be due to the loss of alcohol present in 
formulation [14]. Entrapment efficiency and in vitro drug diffusion 
of proniosomal gel was found to be 75.43% and 77.12 % 
respectively after one month as shown in table 8 [14-15]. 
Skin irritation study 
No erythema was found after 24 h when optimized formulation PG3 
was applied on dorsal surface of rat shown in fig. 6. The rats were 
kept under observation for 24 h [13]. 
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Zone of inhibition* 
Std. NS solution (mm) PG3 formulation (mm) Marketed formulation (mm) 
1 100µg/ml 12±0.02 13±0.01 12.4±0.04 
2 50µg/ml 10±0.05 11±0.03 11±0.01 
*Above values indicate mean±SD (n=3) 
 
Table 8: Stability data of proniosomal gel formulation PG3 at room temperature 
S. No. Parameter Initial* After 1 mo* 
1 % EE 77.96 % 75.43 % 
2 In vitro diffusion study 78.39 % 77.12 % 
*Above values indicate mean (n=3) 
 
 
Fig. 6: Skin irritation test a. Before application b. After 24 h. of application of formulation PG3 
 
CONCLUSION 
Proniosomal gel formulated by using combination of span 60, lecithin 
and cholesterol and carbopol 934 can be used to enhance skin delivery 
of Neomycin Sulphate because of excellent permeation of drug. The PG3 
formulation showed good entrapment efficiency as well as optimum 
drug release during diffusion experiments with optimum ratio of span 
60 and lecithin. The microbiological studies revealed that the optimized 
formulation (PG3) was more active against staphylococcus aureus 
species than the standard solution of NS and marketed cream 
formulation of NS,no skin irritation and good stability. The studies have 
been shown the promising results; hence there is feasibility of delivery of 
NS through the topical gel. Thus, the developed topical proniosomal 
formulation may prove to be a promising carrier for NS. 
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